1
|
Domange C, Canlet C, Traoré A, Biélicki G, Keller C, Paris A, Priymenko N. Orthologous Metabonomic Qualification of a Rodent Model Combined with Magnetic Resonance Imaging for an Integrated Evaluation of the Toxicity of Hypochœris radicata. Chem Res Toxicol 2008; 21:2082-96. [DOI: 10.1021/tx800159x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Céline Domange
- UMR 1089 INRA/ENVT, 180 Chemin de Tournefeuille, BP 3, F-31931 Toulouse, INRA Clermont-Ferrand/Theix QuaPA STIM, F-63122 St. Genès Champanelle, and Department of Nutrition and Botanic and Vegetal Toxicology, ENVT, 23 Chemin des Capelles, F-31300 Toulouse, France
| | - Cécile Canlet
- UMR 1089 INRA/ENVT, 180 Chemin de Tournefeuille, BP 3, F-31931 Toulouse, INRA Clermont-Ferrand/Theix QuaPA STIM, F-63122 St. Genès Champanelle, and Department of Nutrition and Botanic and Vegetal Toxicology, ENVT, 23 Chemin des Capelles, F-31300 Toulouse, France
| | - Amidou Traoré
- UMR 1089 INRA/ENVT, 180 Chemin de Tournefeuille, BP 3, F-31931 Toulouse, INRA Clermont-Ferrand/Theix QuaPA STIM, F-63122 St. Genès Champanelle, and Department of Nutrition and Botanic and Vegetal Toxicology, ENVT, 23 Chemin des Capelles, F-31300 Toulouse, France
| | - Guy Biélicki
- UMR 1089 INRA/ENVT, 180 Chemin de Tournefeuille, BP 3, F-31931 Toulouse, INRA Clermont-Ferrand/Theix QuaPA STIM, F-63122 St. Genès Champanelle, and Department of Nutrition and Botanic and Vegetal Toxicology, ENVT, 23 Chemin des Capelles, F-31300 Toulouse, France
| | - Cécile Keller
- UMR 1089 INRA/ENVT, 180 Chemin de Tournefeuille, BP 3, F-31931 Toulouse, INRA Clermont-Ferrand/Theix QuaPA STIM, F-63122 St. Genès Champanelle, and Department of Nutrition and Botanic and Vegetal Toxicology, ENVT, 23 Chemin des Capelles, F-31300 Toulouse, France
| | - Alain Paris
- UMR 1089 INRA/ENVT, 180 Chemin de Tournefeuille, BP 3, F-31931 Toulouse, INRA Clermont-Ferrand/Theix QuaPA STIM, F-63122 St. Genès Champanelle, and Department of Nutrition and Botanic and Vegetal Toxicology, ENVT, 23 Chemin des Capelles, F-31300 Toulouse, France
| | - Nathalie Priymenko
- UMR 1089 INRA/ENVT, 180 Chemin de Tournefeuille, BP 3, F-31931 Toulouse, INRA Clermont-Ferrand/Theix QuaPA STIM, F-63122 St. Genès Champanelle, and Department of Nutrition and Botanic and Vegetal Toxicology, ENVT, 23 Chemin des Capelles, F-31300 Toulouse, France
| |
Collapse
|
2
|
Broom KA, Anthony DC, Lowe JP, Griffin JL, Scott H, Blamire AM, Styles P, Perry VH, Sibson NR. MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes. Neurobiol Dis 2007; 26:707-17. [PMID: 17490889 DOI: 10.1016/j.nbd.2007.04.001] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2007] [Revised: 03/28/2007] [Accepted: 04/01/2007] [Indexed: 11/17/2022] Open
Abstract
Prion diseases are fatal chronic neurodegenerative diseases. Previous qualitative magnetic resonance imaging (MRI) and spectroscopy (MRS) studies report conflicting results in the symptomatic stages of the disease, but little work has been carried out during the earlier stages of the disease. Here we have used the murine ME7 model of prion disease to quantitatively investigate MRI and MRS changes during the period prior to the onset of overt clinical signs (20+ weeks) and have correlated these with pathological and behavioural abnormalities. Using in vivo MRI, at the later stages of the preclinical period (18 weeks) the diffusion of tissue water was significantly reduced, coinciding with significant microglial activation and behavioural hyperactivity. Using in vivo MRS, we found early (12 weeks) decreases in the ratio of N-acetyl aspartate to both choline (NAA/Cho) and creatine (NAA/Cr) in the thalamus and hippocampus, which were associated with early behavioural deficits. Ex vivo MRS of brain extracts confirmed and extended these findings, showing early (8-12 weeks) decreases in both the neuronal metabolites NAA and glutamate, and the metabolic metabolites lactate and glucose. Increases in the glial metabolite myo-inositol were observed at later stages when microglial and astrocyte activation is substantial. These changes in MRI and MRS signals, which precede overt clinical signs of disease, could provide insights into the pathogenesis of this disease and may enable early detection of pathology.
Collapse
Affiliation(s)
- Kerry A Broom
- Experimental Neuroimaging Group, Department of Physiology, Anatomy and Genetics, University of Oxford, Sherrington Building, Parks Rd., Oxford, OX1 3PT, UK
| | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Fulbright RK, Kingsley PB, Guo X, Hoffmann C, Kahana E, Chapman JC, Prohovnik I. The imaging appearance of Creutzfeldt-Jakob disease caused by the E200K mutation. Magn Reson Imaging 2006; 24:1121-9. [PMID: 17071334 DOI: 10.1016/j.mri.2006.07.001] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2005] [Revised: 07/05/2006] [Accepted: 07/05/2006] [Indexed: 11/26/2022]
Abstract
The E200K mutation on chromosome 20 can cause familial Creutzfeldt-Jakob disease (CJD). Patients with this mutation are clinically similar to those with sporadic CJD, but their imaging features are not well documented. We report here the quantitative and qualitative evaluation of the magnetic resonance (MR) imaging characteristics of this unique group of patients using three-dimensional spoiled gradient recalled (SPGR) echo images, diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) measurements, MR spectroscopy and a fluid-attenuated inversion recovery (FLAIR) sequence. The SPGR and ADC data were analyzed with SPM99. ANCOVA and regression models were used for a region-of-interest (ROI) analysis of ADC and metabolic ratios. CJD patients had a decreased fraction of gray matter and an increased fraction of cerebrospinal fluid (P=.001) in the cortex and cerebellum and increased ADC values in the cortex (P<.001). Focal decreases of ADC were found in the putamen via ROI analysis (548+/-83 vs. 709+/-9 microm(2)/s, P=.02). N-acetyl aspartate (NAA) was generally reduced, with the NAA/Cho ratio lowest in the cingulate gyrus. Qualitative assessment revealed hyperintensities on FLAIR, DWI or both in the putamen (three out of four patients), caudate (three out of four patients) and thalamus. These results provide a framework for future study of patients with genetically defined familial CJD.
Collapse
Affiliation(s)
- Robert K Fulbright
- Department of Radiology, Yale University School of Medicine, MRRC, The Anlyan Center N137, P.O. Box 208043, New Haven, CT 06520-8043, USA.
| | | | | | | | | | | | | |
Collapse
|
4
|
Kado H, Kimura H, Murata T, Nagata K, Kanno I. Depressive psychosis: clinical usefulness of MR spectroscopy data in predicting prognosis. Radiology 2006; 238:248-55. [PMID: 16373773 DOI: 10.1148/radiol.2381041375] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
PURPOSE To prospectively assess the usefulness of magnetic resonance (MR) spectroscopy data acquired before the initiation of medical therapy in predicting prognosis in patients with depressive psychosis. MATERIALS AND METHODS All subjects gave written informed consent to an institutional committee for clinical research-approved study protocol. The clinical course after medication in 52 patients with depressive psychosis (age range, 52-78 years; 21 men, 31 women) was investigated. In all patients, MR spectroscopy was performed with a 1.5-T MR imaging unit before the initiation of medical therapy. Cerebrovascular lesions (CVLs), which appear as high-signal-intensity areas on T2-weighted MR images, were evaluated by using the Fazekas rating scale. Patients were classified into two groups on the basis of the ratio of N-acetylaspartate (NAA) to creatine and phosphocreatine (Cr): Patients in group A had an NAA/Cr ratio greater than 1.91, and patients in group B had an NAA/Cr ratio of 1.91 or less. To assess the response of the patients to medication, standard psychiatric tests--the Verbal Associative Fluency Test (VAFT), the Digit Symbol Test (DST), the Mini-Mental State Examination (MMSE), and the Hamilton Depression Rating Scale (HAM-D)--were administered before and after medical therapy was initiated. Mean test scores before and after medication were compared with paired t testing. P < .05 was considered to indicate a significant difference. RESULTS There were 25 patients in group A and 27 in group B. In group A, the mean VAFT and DST scores increased and the mean HAM-D score decreased after medication. There was no significant difference in mean MMSE scores before and after medication (P = .945 for group A and P = .934 for group B). In group B, there were no significant differences in any of the psychiatric test scores before and after medication. The high-signal-intensity area score in group B was significantly higher than that in group A (P = .004). CONCLUSION MR spectroscopy data obtained before the initiation of medical therapy were useful in predicting prognosis in patients with depressive psychosis; this suggests that the combined burden of all CVLs may affect the response to antidepressant medication.
Collapse
Affiliation(s)
- Hirotsugu Kado
- Department of Radiology, Akita Research Institute for Brain and Blood Vessels, 6-10 Kubotamachi, Sensyu, Akita 010-0874, Japan
| | | | | | | | | |
Collapse
|
5
|
Vidal C, Méric P, Provost F, Herzog C, Lasmézas C, Gillet B, Beloeil JC, Dormont D. Preclinical metabolic changes in mouse prion diseases detected by 1H-nuclear magnetic resonance spectroscopy. Neuroreport 2006; 17:89-93. [PMID: 16361957 DOI: 10.1097/01.wnr.0000194389.89536.88] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Magnetic resonance spectroscopy studies in animal models of prion disease are very few and concern terminal stages of infection. In order to study earlier stages of the disease, we used in-vivo magnetic resonance spectroscopy in a mouse model of scrapie and, for the first time, in mice infected with a bovine spongiform encephalopathy strain. In bovine spongiform encephalopathy-infected mice, we observed an increase in myo-inositol preceding clinical signs by 20 days, followed by a decrease in N-acetylaspartate at advanced stages. In scrapie-infected mice, changes in N-acetylaspartate and myo-inositol were detected at the beginning of the symptomatic phase. These results show that magnetic resonance spectroscopy is a valuable tool for detecting subtle metabolic changes associated to gliosis and neuronal dysfunction in prion diseases.
Collapse
Affiliation(s)
- Catherine Vidal
- CEA (Atomic Energy Commission), Laboratory of Neurovirology, Fontenay-aux-Roses, France.
| | | | | | | | | | | | | | | |
Collapse
|
6
|
Boska MD, Lewis TB, Destache CJ, Benner EJ, Nelson JA, Uberti M, Mosley RL, Gendelman HE. Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease. J Neurosci 2005; 25:1691-700. [PMID: 15716405 PMCID: PMC6725925 DOI: 10.1523/jneurosci.4364-04.2005] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Nigrostriatal degeneration, the pathological hallmark of Parkinson's disease (PD), is mirrored by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication. MPTP-treated animals show the common behavioral, motor, and pathological features of human disease. We demonstrated previously that adoptive transfer of Copaxone (Cop-1) immune cells protected the nigrostriatal dopaminergic pathway in MPTP-intoxicated mice. Herein, we evaluated this protection by quantitative proton magnetic resonance spectroscopic imaging (1H MRSI). 1H MRSI performed in MPTP-treated mice demonstrated that N-acetyl aspartate (NAA) was significantly diminished in the substantia nigra pars compacta (SNpc) and striatum, regions most affected in human disease. When the same regions were coregistered with immunohistochemical stains for tyrosine hydroxylase, numbers of neuronal bodies and termini were similarly diminished. MPTP-intoxicated animals that received Cop-1 immune cells showed NAA levels, in the SNpc and striatum, nearly equivalent to PBS-treated animals. Moreover, adoptive transfer of immune cells from ovalbumin-immunized to MPTP-treated mice failed to alter NAA levels or protect dopaminergic neurons and their projections. These results demonstrate that 1H MRSI can evaluate dopaminergic degeneration and its protection by Cop-1 immunization strategies. Most importantly, the results provide a monitoring system to assess therapeutic outcomes for PD.
Collapse
Affiliation(s)
- Michael D Boska
- Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska 68198-5215, USA
| | | | | | | | | | | | | | | |
Collapse
|
7
|
Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, Volpe BT. Cognition and immunity; antibody impairs memory. Immunity 2004; 21:179-88. [PMID: 15308099 DOI: 10.1016/j.immuni.2004.07.011] [Citation(s) in RCA: 268] [Impact Index Per Article: 13.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2004] [Revised: 05/16/2004] [Accepted: 06/07/2004] [Indexed: 10/26/2022]
Abstract
Patients with lupus (SLE) experience progressive cognitive loss without evidence of CNS vascular disease or inflammation. SLE patients produce anti-DNA antibodies that crossreact with NMDA receptors and are capable of mediating excitotoxic death. We now show that mice induced by antigen to express these antibodies have no neuronal damage until breakdown of the blood-brain barrier occurs. Following administration of lipopolysaccharide (LPS) to immunized mice, antibodies gain access to the brain. They bind preferentially to hippocampal neurons and cause neuronal death with resulting cognitive dysfunction and altered hippocampal metabolism on magnetic resonance spectroscopy. Memantine, an NMDA receptor antagonist, given prior to LPS administration, prevents neuronal damage. Thus, systemic immune responses can cause cognitive impairment in the absence of an inflammatory cascade, implicating the immune system in yet another arena of human pathobiology. Furthermore, NMDA receptor antagonists prevent antibody-mediated damage and may constitute a new approach to therapy in SLE.
Collapse
Affiliation(s)
- Czeslawa Kowal
- Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA
| | | | | | | | | | | | | |
Collapse
|